Together against the pandemic
As part of the campaign "We defeat Coivd-19!", the Adalbert-Raps-Stiftung supports Corona drug research.
With the goal of being able to provide a medication against the Sars-CoV-2 virus, the three Erlangen researchers, Prof. Dr. Hans-Martin Jäck, Prof. Dr. Thomas Winkler and Prof. Dr. Klaus Überla, developed a highly effective antibody. In order to be able to finance both the production and the necessary test studies, they launched the campaign "We defeat Covid-19!". They appealed to Bavarian industry and asked for support - with success! The Adalbert-Raps-Stiftung also supported the research project with 10,000 euros.
Bavarian industry makes a strong stand against the pandemic
In the fight against the Corona pandemic, three Erlangen researchers, Prof. Dr. Hans-Martin Jäck, Prof. Dr. Thomas Winkler and Prof. Dr. Klaus Überla, have succeeded in developing a highly effective antibody and thus a promising medication against the Sars-CoV-2 virus using a patented model. In order to be able to finance the production of the antibody and the test studies necessary for approval, the researchers launched the campaign "We Defeat Covid-19" under the umbrella of the non-profit foundation "Research for Life". The aim of the campaign was to generate the necessary financial resources with the help of the Bavarian economy, primarily the DAX corporations and larger medium-sized companies. The Adalbert-Raps-Stiftung also showed commitment to the fight against Covid-19 and supported the campaign with 10,000 euros. Although the loan could not be approved in the end, the campaign was a complete success: with the funds raised, corona antibody research can be further advanced.
You can find the full press release here.